Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

12.67
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
3.82
Today|||52-Week Range
16.94
+107.70%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close12.67
Today’s open12.67
Day’s range12.34 - 12.96
Volume222,266
Average volume (3 months)456,237
Market cap$430.9M
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)-123.88%
Earnings growth (this year)+26.80%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.91%
P/E ratioNM
Price/Sales7,008.84
Price/Book8.27

Competitors

 Today’s
change
Today’s
% change
AVDLAvadel Pharmaceutica...0.000.00%
IOVAIovance Biotherapeut...0.000.00%
DEPODepomed Inc0.000.00%
SVASinovac Biotech Ltd0.000.00%
Data as of 1:00pm ET, 11/24/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$18.5K
Annual profit (last year)-$31.8M
Net profit margin-171,945.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts